These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8971700

  • 41. Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease.
    Russ C, Lovestone S, Powell JF.
    Mol Psychiatry; 2002; 7(1):104-9. PubMed ID: 11803455
    [Abstract] [Full Text] [Related]

  • 42. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
    Forlenza OV, Spink JM, Dayanandan R, Anderton BH, Olesen OF, Lovestone S.
    J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
    [Abstract] [Full Text] [Related]

  • 43. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ, Chen GH, Hu XY, Lu YP, Zhou JN, Liu RY.
    Brain Res; 2005 Jan 07; 1031(1):101-8. PubMed ID: 15621017
    [Abstract] [Full Text] [Related]

  • 44. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.
    Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E.
    FEBS Lett; 1992 Dec 21; 314(3):315-21. PubMed ID: 1334849
    [Abstract] [Full Text] [Related]

  • 45. GSK-3 is essential in the pathogenesis of Alzheimer's disease.
    Takashima A.
    J Alzheimers Dis; 2006 Dec 21; 9(3 Suppl):309-17. PubMed ID: 16914869
    [Abstract] [Full Text] [Related]

  • 46. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH.
    Neurosci Lett; 1992 Nov 23; 147(1):58-62. PubMed ID: 1336152
    [Abstract] [Full Text] [Related]

  • 47. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
    Mondragón-Rodríguez S, Perry G, Luna-Muñoz J, Acevedo-Aquino MC, Williams S.
    Neuropathol Appl Neurobiol; 2014 Feb 23; 40(2):121-35. PubMed ID: 24033439
    [Abstract] [Full Text] [Related]

  • 48. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T, Mukai H, Oishi K, Taniguchi T, Hasegawa H, Kawamata T, Tanaka C, Ono Y.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):209-12. PubMed ID: 10873588
    [Abstract] [Full Text] [Related]

  • 49. Molecular pathology of Alzheimer neurofibrillary degeneration.
    Iqbal K, Alonso A, Gong C, Khatoon S, Kudo T, Singh T, Grundke-Iqbal I.
    Acta Neurobiol Exp (Wars); 1993 Jun 24; 53(1):325-35. PubMed ID: 8317268
    [Abstract] [Full Text] [Related]

  • 50. Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities.
    Delobel P, Flament S, Hamdane M, Delacourte A, Vilain JP, Buée L.
    FEBS Lett; 2002 Apr 10; 516(1-3):151-5. PubMed ID: 11959122
    [Abstract] [Full Text] [Related]

  • 51. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R, Lee VM, Leight S, Varga I, Otvos L.
    Biochemistry; 1997 Jul 01; 36(26):8114-24. PubMed ID: 9201960
    [Abstract] [Full Text] [Related]

  • 52. 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.
    Agarwal-Mawal A, Qureshi HY, Cafferty PW, Yuan Z, Han D, Lin R, Paudel HK.
    J Biol Chem; 2003 Apr 11; 278(15):12722-8. PubMed ID: 12551948
    [Abstract] [Full Text] [Related]

  • 53. The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    Dugger BN, Whiteside CM, Maarouf CL, Walker DG, Beach TG, Sue LI, Garcia A, Dunckley T, Meechoovet B, Reiman EM, Roher AE.
    J Alzheimers Dis; 2016 Apr 11; 51(2):345-56. PubMed ID: 26890756
    [Abstract] [Full Text] [Related]

  • 54. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW, Lee VM, Trojanowski JQ.
    Histol Histopathol; 1995 Oct 11; 10(4):969-78. PubMed ID: 8574016
    [Abstract] [Full Text] [Related]

  • 55. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.
    Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, Seereeram A, Reynolds CH, Ward MA, Anderton BH.
    J Biol Chem; 2007 Aug 10; 282(32):23645-54. PubMed ID: 17562708
    [Abstract] [Full Text] [Related]

  • 56. Phosphorylation of tau by glycogen synthase kinase-3 beta in vitro produces species with similar electrophoretic and immunogenic properties to PHF-tau from Alzheimer's disease brain.
    Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP.
    Biochem Soc Trans; 1995 Feb 10; 23(1):45S. PubMed ID: 7758758
    [No Abstract] [Full Text] [Related]

  • 57. Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules.
    Ikegami K, Kimura T, Katsuragi S, Ono T, Yamamoto H, Miyamoto E, Miyakawa T.
    Psychiatry Clin Neurosci; 1996 Jun 10; 50(3):137-40. PubMed ID: 9201760
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease.
    Xiao J, Perry G, Troncoso J, Monteiro MJ.
    J Neuropathol Exp Neurol; 1996 Sep 10; 55(9):954-63. PubMed ID: 8800091
    [Abstract] [Full Text] [Related]

  • 60. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD, Song JS, Yu JS, Shiah SG.
    J Neurochem; 1993 Nov 10; 61(5):1742-7. PubMed ID: 8228990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.